ArticleFrontiers in immunology2026
A peri-tumoral TREM2-high myeloid state, myeloid continuum polarization, and white matter disconnection in long-term cognitive survivorship after diffuse glioma: a neuroimmune-connectomic cohort study.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Whether a TREM2-high myeloid state and myeloid continuum polarization are associated with long-term cognitive survivorship in diffuse glioma has not been integrated with white matter connectomics and systemic neuroinflammation in a longitudinal framework. Methods: In a single-center retrospective cohort of 214 adults with WHO grade 2-4 diffuse glioma (168 IDH-mutant and 46 IDH-wildtype; median follow-up, 5.2 years), a 6-plex tyramide-amplified multiplex immunofluorescence panel was applied to 186 tumors. FlowSOM meta-clustering of 2.41 × 10 Results: FlowSOM resolved six marker-defined meta-clusters (bootstrap Jaccard, 0.78-0.88). C4 was TREM2-high with all other panel markers intermediate (17.1% of myeloid cells), was enriched in peri-tumoral white matter relative to tumor core (21.0% vs. 13.8%, P < 0.001), and remained associated with arcuate fasciculus (AF) disconnection after adjustment for GAM-PCI (β = 0.21 per 10-percentage-point increase, P = 0.002). CD163+CD206+ cells showed greater spatial colocalization with myelin basic protein fragments in peri-tumoral white matter (Morisita-Horn index, 0.71 [0.58-0.82]) than at the infiltrative margin (0.42 [0.31-0.55]; P < 0.001), and their mean distance to the white matter boundary was 38 ± 14 µm versus a null median of 87 µm (P < 0.001). In 45 paired serum-tissue cases, T2 serum sTREM2 was associated with the peri-tumoral C4 proportion (Spearman ρ = 0.42, P = 0.004). Long-term cognitive decline occurred in 88 of 214 patients (41.1%), and AF disconnection independently predicted impairment (adjusted odds ratio, 1.52 per 10% increase; 95% CI, 1.25-1.88). In 162 complete tissue-connectomic cases, the model-based serial indirect association through MBP loss and AF disconnection was β = -0.19 (95% CI, -0.29 to -0.10; P < 0.001). In a separate 45-patient serum-path model, the estimated indirect association through T2 sTREM2/IL-6 was β = -0.06 (95% CI, -0.11 to -0.02; P = 0.004). The AF × IDH interaction was significant (P = 0.032), whereas a difference in C4 proportion by IDH status was not detected and equivalence was not established (TOST P = 0.078). Conclusion: In this observational cohort, marker-defined peri-tumoral myeloid states, white matter disconnection, and systemic neuroimmune abnormalities were associated with long-term cognitive outcome. The mediation analysis provide model-dependent structural decompositions under stated assumptions and do not establish causal direction, cellular origin, or treatment effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.